Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ratio (functional) | = 1.7 | Ratio between brain tumor full panel [A] and sub panel [B] | ChEMBL. | 8035425 |
TGI (functional) | = 20 uM | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in brain tumor sub panel | ChEMBL. | 8035425 |
TGI (functional) | = 34 uM | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in full panel | ChEMBL. | 8035425 |
TGI concentration (functional) | = 20 uM | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in brain tumor sub panel | ChEMBL. | 8035425 |
TGI concentration (functional) | = 34 uM | Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in full panel | ChEMBL. | 8035425 |
TGI correlation coefficient (functional) | = 0.71 | TGI correlation coefficient value of the compound | ChEMBL. | 8035425 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.